Filing Details

Accession Number:
0001209191-12-008786
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-02-09 17:50:30
Reporting Period:
2012-02-08
Filing Date:
2012-02-09
Accepted Time:
2012-02-09 17:50:30
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1461993 Cempra Inc. CEMP Pharmaceutical Preparations (2834) 262644445
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1189158 Sherrill P Neff C/O Quaker Bioventures
Cira Centre, 2929 Arch Street
Philadelphia PA 19104
Yes No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2012-02-08 1,189,805 $6.00 3,262,154 No 4 P Indirect by Quaker BioVentures II, L.P.
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect by Quaker BioVentures II, L.P.
Footnotes
  1. These shares were purchased in the Issuer's initial public offering.
  2. The reportable securities are owned directly by Quaker BioVentures II, L.P. ("Quaker"). The shares held directly by Quaker are indirectly held by Quaker BioVentures Capital II, L.P. ("Quaker GP"), as general partner of Quaker, and by Quaker BioVentures Capital II, LLC ("Quaker LLC"), as general partner of Quaker GP. As a result of the control that Quaker GP exercises over Quaker, and the control that Quaker LLC exercises of Quaker GP, each of Quaker GP and Quaker LLC may be deemed to beneficially own these securities. P. Sherrill Neff is a director of the Issuer and a managing member of Quaker LLC. Mr. Neff disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest therein.